Advertisement
Screener

Harrow, Inc. (HROW) Proceeds from Contributed Capital

2.8 / 5 stars · 68/120 Roast Me

Harrow, Inc. Proceeds from Contributed Capital

Harrow, Inc. (HROW) reported Proceeds from Contributed Capital of $168.71 thousand for the 188-month period ending 2014-03-31, per its 10-Q filed 2014-05-15.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromContributedCapital · last filed 2014-05-15

  • Harrow, Inc. proceeds from contributed capital for the quarter ending 2013-03-31 was $0.00.
  • Harrow, Inc. proceeds from contributed capital for the quarter ending 2012-03-31 was $0.00.
  • Harrow, Inc. proceeds from contributed capital for the quarter ending 2011-12-31 was $0.00.
  • Harrow, Inc. proceeds from contributed capital for the quarter ending 2011-09-30 was $0.00.
  • Harrow, Inc. proceeds from contributed capital for fiscal 2012 was $0.00.
  • Harrow, Inc. proceeds from contributed capital for fiscal 2011 was $0.00.
  • Harrow, Inc. proceeds from contributed capital for fiscal 2010 was $0.00.
  • Harrow, Inc. proceeds from contributed capital for fiscal 2007 was $105.91K, a 117.92% increase from fiscal 2006.
Period endProceeds from Contributed Capital 3 monthProceeds from Contributed Capital 6 monthProceeds from Contributed Capital 9 monthProceeds from Contributed Capital 12 monthProceeds from Contributed Capital 155 monthProceeds from Contributed Capital 158 monthProceeds from Contributed Capital 161 monthProceeds from Contributed Capital 164 monthProceeds from Contributed Capital 167 monthProceeds from Contributed Capital 170 monthProceeds from Contributed Capital 173 monthProceeds from Contributed Capital 176 monthProceeds from Contributed Capital 182 monthProceeds from Contributed Capital 185 monthProceeds from Contributed Capital 188 month
2014-03-31$168.71K
10-Q · filed 2014-05-15
2013-12-31$168.71K
10-K · filed 2014-03-28
2013-09-30$168.71K
10-Q · filed 2013-11-06
2013-06-30$168.71K
10-Q · filed 2013-08-14
2013-03-31$0.00
10-Q · filed 2013-05-08
$168.71K
10-Q · filed 2013-05-08
2012-12-31$0.00
10-K · filed 2013-03-18
$168.71K
10-K · filed 2013-03-18
2012-09-30$168.71K
10-Q · filed 2012-11-14
2012-06-30$168.71K
10-Q · filed 2012-08-14
2012-03-31$0.00
10-Q · filed 2013-05-08
$0.00
derived: sum of 2 quarters · filed 2013-05-08
$0.00
derived: sum of 3 quarters · filed 2013-05-08
$0.00
derived: sum of 4 quarters · filed 2013-05-08
$168.71K
10-Q · filed 2012-05-10
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$0.00
derived: sum of 2 quarters · filed 2013-03-18
$0.00
derived: sum of 3 quarters · filed 2013-03-18
$0.00
10-K · filed 2013-03-18
$168.71K
10-K · filed 2012-02-23
2011-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-23
$0.00
derived: sum of 2 quarters · filed 2012-02-23
$0.00
10-Q · filed 2012-02-23
$0.00
derived: sum of 4 quarters · filed 2012-05-10
$168.71K
10-Q · filed 2012-02-23
2011-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-23
$0.00
10-Q · filed 2012-02-23
$0.00
derived: sum of 3 quarters · filed 2012-05-10
$0.00
derived: sum of 4 quarters · filed 2012-05-10
$168.71K
10-Q · filed 2012-02-23
2011-03-31$0.00
10-Q · filed 2012-05-10
$0.00
derived: sum of 2 quarters · filed 2012-05-10
$0.00
derived: sum of 3 quarters · filed 2012-05-10
2010-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23
$0.00
derived: sum of 2 quarters · filed 2012-02-23
$0.00
10-K · filed 2012-02-23
2010-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-23
$0.00
10-Q · filed 2012-02-23
2010-06-30$0.00
10-Q · filed 2012-02-23
2007-12-31$105.91K
10-K · filed 2014-03-28
2006-12-31$48.60K
10-K · filed 2014-03-28
2005-12-31$14.20K
10-K · filed 2014-03-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Damora Therapeutics, Inc. (DMRA)$1.250B-6.10
OPKO HEALTH, INC. (OPK)United States$1.220B-15.59
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87
Avalyn Pharma Inc. (AVLN)United States$1.267B
First Tracks Biotherapeutics, Inc. (TRAX)United States$1.280B
Jaguar Health, Inc. (JAGX)United States$1.184B
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Tyra Biosciences, Inc. (TYRA)United States$1.337B-12.83
Kardigan, Inc. (KARD)United States$1.346B